Thyrocare Technologies Limited has informed the Exchange regarding Resignation of Dharmil Nirupam Sheth and Dhaval Rajesh Shah as Non- Executive Directors of the company w.e.f. closure of business hours of May 07, 2026

Thyrocare Technologies' Board meeting on May 7, 2026 resulted in multiple key decisions. Two Non-Executive, Non-Independent Directors - Mr. Dharmil Nirupam Sheth and Dr. Dhaval Rajesh Shah - resigned effective close of business hours on May 7, 2026, citing pre-occupation and other commitments. Both confirmed no material reasons for resignation. Simultaneously, two new Additional Directors - Mr. Uday Patel Kadam and Mr. Gaurav Verma - were appointed from API Holdings Limited (the parent company). The Board also re-appointed Mr. Rahul Franklin Guha as Chairman, Managing Director & CEO for five years (2027-2032). Other decisions include recommending a final dividend of Rs. 7 per share (total FY26 dividend Rs. 9.33 per share post-bonus), appointing Price Waterhouse Chartered Accountants LLP as new statutory auditors for five years, and approving up to Rs. 5.5 crore investment in wholly-owned subsidiary Think Health Diagnostics Private Limited. The Board also approved altering the Memorandum of Association to align with the Companies Act, 2013 and expand its healthcare business scope.